BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31848818)

  • 21. Total submission of pelvic lymphadenectomy tissues removed during radical prostatectomy for prostate cancer increases lymph node yield and detection of micrometastases.
    Perry-Keene J; Ferguson P; Samaratunga H; Nacey JN; Delahunt B
    Histopathology; 2014 Feb; 64(3):399-404. PubMed ID: 24118022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion.
    Preisser F; Bandini M; Marchioni M; Nazzani S; Tian Z; Pompe RS; Fossati N; Briganti A; Saad F; Shariat SF; Heinzer H; Huland H; Graefen M; Tilki D; Karakiewicz PI
    Prostate; 2018 May; 78(6):469-475. PubMed ID: 29460290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is a limited lymphadenectomy targeting obturator nodes alone an adequate procedure for Japanese men undergoing radical prostatectomy?
    Miyake H; Sakai I; Harada K; Hara I; Eto H
    Int J Urol; 2005 Aug; 12(8):739-44. PubMed ID: 16174048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The incidence of lymph node metastases in prostate carcinoma depends not only on tumor characteristics but also on surgical performance and extent of pelvic lymphadenectomy.
    Klevecka V; Musch M; Roggenbuck U; Stoerkel S; Kroepfl D
    Medicina (Kaunas); 2008; 44(8):601-8. PubMed ID: 18791337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Robotic-assisted pelvic lymph node dissection for prostate cancer: frequency of nodal metastases and oncological outcomes.
    Ledezma RA; Negron E; Razmaria AA; Dangle P; Eggener SE; Shalhav AL; Zagaja GP
    World J Urol; 2015 Nov; 33(11):1689-94. PubMed ID: 25701128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymph node-positive prostate cancer after robotic prostatectomy and extended pelvic lymphadenectomy.
    Chenam A; Parihar JS; Ruel N; Pal S; Avila Y; Yamzon J; Lau C; Yuh B
    J Robot Surg; 2018 Sep; 12(3):425-431. PubMed ID: 28905289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of required nodal yield in a high risk cohort undergoing extended pelvic lymphadenectomy in robotic-assisted radical prostatectomy and its impact on functional outcomes.
    Sagalovich D; Calaway A; Srivastava A; Sooriakumaran P; Tewari AK
    BJU Int; 2013 Jan; 111(1):85-94. PubMed ID: 22823452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extended vs standard pelvic lymphadenectomy during laparoscopic radical prostatectomy for intermediate- and high-risk prostate cancer.
    Eden CG; Arora A; Rouse P
    BJU Int; 2010 Aug; 106(4):537-42. PubMed ID: 20132202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer.
    Briganti A; Chun FK; Salonia A; Gallina A; Farina E; Da Pozzo LF; Rigatti P; Montorsi F; Karakiewicz PI
    BJU Int; 2006 Oct; 98(4):788-93. PubMed ID: 16796698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between Radical Prostatectomy and Survival in Men with Clinically Node-positive Prostate Cancer.
    Sarkar RR; Bryant AK; Parsons JK; Ryan ST; Karim Kader A; Kane CJ; McKay RR; Sandhu A; Murphy JD; Rose BS
    Eur Urol Oncol; 2019 Sep; 2(5):584-588. PubMed ID: 31411995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilization of Pelvic Lymph Node Dissection for Patients With Low-Risk Prostate Cancer Treated With Robot-Assisted Radical Prostatectomy.
    Modi PK; Bock M; Kim S; Singer EA; Parikh RR
    Clin Genitourin Cancer; 2017 Dec; 15(6):e1001-e1006. PubMed ID: 28558990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.
    Bhatta-Dhar N; Reuther AM; Zippe C; Klein EA
    Urology; 2004 Mar; 63(3):528-31. PubMed ID: 15028451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current controversies on the role of lymphadenectomy for prostate cancer.
    Chalouhy C; Gurram S; Ghavamian R
    Urol Oncol; 2019 Mar; 37(3):219-226. PubMed ID: 30579787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
    DiMarco DS; Zincke H; Sebo TJ; Slezak J; Bergstralh EJ; Blute ML
    J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prospective study of extended versus limited lymphadenectomy in patients undergoing radical prostatectomy with localized prostate cancer].
    Matsumoto R; Sakashita S
    Hinyokika Kiyo; 2011 Jul; 57(7):359-62. PubMed ID: 21832869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Multi-institutional Analysis of Perioperative Outcomes in 106 Men Who Underwent Radical Prostatectomy for Distant Metastatic Prostate Cancer at Presentation.
    Sooriakumaran P; Karnes J; Stief C; Copsey B; Montorsi F; Hammerer P; Beyer B; Moschini M; Gratzke C; Steuber T; Suardi N; Briganti A; Manka L; Nyberg T; Dutton SJ; Wiklund P; Graefen M
    Eur Urol; 2016 May; 69(5):788-94. PubMed ID: 26038098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of postoperative radiotherapy after pelvic lymphadenectomy and radical retropubic prostatectomy: a single institute experience of 415 patients.
    Cozzarini C; Bolognesi A; Ceresoli GL; Fiorino C; Rossa A; Bertini R; Colombo R; Da Pozzo L; Montorsi F; Roscigno M; Calandrino R; Rigatti P; Villa E
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):674-83. PubMed ID: 15183470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changing patterns of pelvic lymphadenectomy for prostate cancer: results from CaPSURE.
    Kawakami J; Meng MV; Sadetsky N; Latini DM; Duchane J; Carroll PR;
    J Urol; 2006 Oct; 176(4 Pt 1):1382-6. PubMed ID: 16952638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pelvic node dissection in prostate cancer: extended, limited, or not at all?
    Hyndman ME; Mullins JK; Pavlovich CP
    Curr Opin Urol; 2010 May; 20(3):211-7. PubMed ID: 20224412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.